Platinum Investment Management LTD Centessa Pharmaceuticals PLC Transaction History
Platinum Investment Management LTD
- $1.4 Billion
- Q2 2025
A detailed history of Platinum Investment Management LTD transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Platinum Investment Management LTD holds 290,836 shares of CNTA stock, worth $4.95 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
290,836
Previous 267,887
8.57%
Holding current value
$4.95 Million
Previous $3.85 Million
0.8%
% of portfolio
0.27%
Previous 0.24%
Shares
9 transactions
Others Institutions Holding CNTA
# of Institutions
136Shares Held
124MCall Options Held
163KPut Options Held
816K-
Medicxi Ventures Management (Jersey) LTD20MShares$340 Million74.33% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$170 Million100.0% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$165 Million4.7% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA6.95MShares$118 Million0.19% of portfolio
-
Janus Henderson Group PLC London, X05.92MShares$101 Million0.05% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $1.61B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...